Parkinson's cell transplant trial using your own cells
Part of Brain & nervous system clinical trials.
This trial tests whether transplanting special dopamine-producing cells made from a patient's own skin cells can help treat Parkinson's disease. It is for people who have had Parkinson's for at least 5 years and still respond well to medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had Parkinson's disease for at least 5 years and your symptoms improve with medication by at least 30%.
- You are between 55 and 80 years old.
- You have not had any brain surgeries, including deep brain stimulation.
- You have no major memory or thinking problems, and no untreated depression or serious mental health conditions.
- You have no active cancer, serious heart or blood vessel disease, or uncontrolled diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether implanting your own stem cells (made into dopamine-producing brain cells) can improve Parkinson's motor symptoms. You would need to be a candidate for brain surgery and have a stable medication routine.
This trial tests a new cell treatment for Parkinson's disease. It involves injecting special cells into the brain to see if they can safely replace damaged cells and improve symptoms. It might help people who have had Parkinson's for several years and still respond well to medication.
This trial tests a new treatment made from your own cells to replace damaged brain cells, aiming to improve movement and reduce symptoms. It's for people who have had Parkinson's for at least 4 years and respond well to levodopa.
This trial tests a new cell therapy called NouvNeu001 for Parkinson's disease. It involves a one-time brain surgery to deliver the treatment, and researchers will check if it's safe and helps with symptoms.
This study tests a new treatment for Parkinson's disease where special cells are injected directly into the brain. It aims to reduce 'off' time and improve movement control for people who have had Parkinson's for over 5 years and take levodopa but still experience daily complications.
This early-stage trial tests a new stem cell treatment called NCR201 for people with Parkinson's. It aims to see if the treatment is safe and might help improve symptoms.
Hear when a new Parkinson Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.